These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37236571)

  • 1. Lecithin/chitosan nanoparticle drug carrier improves anti-tumor efficacy of Monascus pigment rubropunctatin.
    Ning S; Wang C; Zhao L; Yang J; Shi X; Zheng Y
    Int J Biol Macromol; 2023 Jul; 242(Pt 3):125058. PubMed ID: 37236571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer effect of rubropunctatin against human gastric carcinoma cells BGC-823.
    Zheng Y; Xin Y; Shi X; Guo Y
    Appl Microbiol Biotechnol; 2010 Nov; 88(5):1169-77. PubMed ID: 20730532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
    Chadha R; Gupta S; Pathak N
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
    Chu XY; Huang W; Wang YL; Meng LW; Chen LQ; Jin MJ; Chen L; Gao CH; Ge C; Gao ZG; Gao CS
    Int J Nanomedicine; 2019; 14():689-705. PubMed ID: 30774330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monascus Pigment Rubropunctatin: A Potential Dual Agent for Cancer Chemotherapy and Phototherapy.
    Zheng Y; Zhang Y; Chen D; Chen H; Lin L; Zheng C; Guo Y
    J Agric Food Chem; 2016 Mar; 64(12):2541-8. PubMed ID: 26953890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib loaded mucoadhesive lecithin-chitosan hybrid nanoparticles for its augmented oral delivery, in-vitro efficacy and safety.
    Mehandole A; Mahajan S; Aalhate M; Kumar R; Maji I; Gupta U; Kumar Guru S; Kumar Singh P
    Int J Pharm; 2024 Feb; 651():123784. PubMed ID: 38185340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol loaded lecithin/chitosan nanoparticles: preparation, characterization, and their potential applications as a sustainable antifungal agent.
    Ilk S; Saglam N; Özgen M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):907-916. PubMed ID: 27265551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Artificial Intelligence with Quality by Design in the Formulation of Lecithin/Chitosan Nanoparticles of a Poorly Water-Soluble Drug.
    Dawoud MHS; Mannaa IS; Abdel-Daim A; Sweed NM
    AAPS PharmSciTech; 2023 Aug; 24(6):169. PubMed ID: 37552427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticancer, anti-oxidant, and antibacterial activities of chitosan-lecithin-coated parthenolide/tyrosol hybrid nanoparticles.
    Bahrani HMH; Ghobeh M; Homayouni Tabrizi M
    J Biomater Sci Polym Ed; 2023 Aug; 34(11):1603-1617. PubMed ID: 36755525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery.
    Şenyiğit T; Sonvico F; Rossi A; Tekmen I; Santi P; Colombo P; Nicoli S; Özer Ö
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis.
    Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
    Int J Pharm; 2021 Oct; 608():121114. PubMed ID: 34543618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated Lecithin-Chitosan-Folic Acid Nanoparticles as Nanocarriers of Allicin for In Vitro Controlled Release and Anticancer Effects.
    Hashemy SI; Amiri H; Hosseini H; Sadeghzadeh F; Jaseem MMM; Tabrizi MH
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4036-4052. PubMed ID: 36652093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of Monascus pigments and their derivatives to human cancer cells.
    Zheng Y; Xin Y; Shi X; Guo Y
    J Agric Food Chem; 2010 Sep; 58(17):9523-8. PubMed ID: 20707312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of a Rubropunctatin-loaded liposome anticancer drug carrier.
    Xu D; Xie J; Feng X; Zhang X; Ren Z; Zheng Y; Yang J
    RSC Adv; 2020 Mar; 10(17):10352-10360. PubMed ID: 35498569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin.
    Hafner A; Lovrić J; Pepić I; Filipović-Grčić J
    J Microencapsul; 2011; 28(8):807-15. PubMed ID: 22117177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated Lecithin-Chitosan Nanoparticle-Encapsulated Alphα-Terpineol for In Vitro Anticancer Effects.
    Zarei B; Tabrizi MH; Rahmati A
    AAPS PharmSciTech; 2022 Mar; 23(4):94. PubMed ID: 35314914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazıcı M; Özer Ö
    Int J Nanomedicine; 2013; 8():461-75. PubMed ID: 23390364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Lecithin/Chitosan Nanoparticles for Promoting Topical Delivery of Propranolol Hydrochloride: Design, Optimization and In-Vivo Evaluation.
    Khalil RM; El Arini SK; AbouSamra MM; Zaki HS; El-Gazaerly ON; Elbary AA
    J Pharm Sci; 2021 Mar; 110(3):1337-1348. PubMed ID: 33271137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.